I

Iambic Therapeutics Tech Stack

AI-driven drug discovery platform advancing candidates to human trials

Biotechnology Research San Diego, California 51–200 employees Founded 2020 Privately Held

Iambic is a clinical-stage biotech using AI to accelerate drug discovery, with candidates already in human trials. The stack reveals a hybrid wet-lab and software operation: HPLC and qPCR (bench chemistry), Python/FastAPI/Airflow (ML/data orchestration), and Databricks/Spark (training infrastructure), paired with Veeva for regulatory workflows. Hiring velocity is accelerating across research, software, and AI/ML roles, but pain points around data integrity, pipeline optimization, and scaling FP&A tools suggest the platform is still maturing operationally as the company grows beyond 50 employees.

Tech Stack 25 technologies

Core StackAshby NetSuite Python FastAPI Prefect Apache Airflow Databricks Apache Spark HPLC Excel Adaptive Planning Anaplan Pydantic asyncio Argo CD qPCR Agilent KNIME Veeva LinkedIn Recruiter

What Iambic Therapeutics Is Building

◆Challenges

Vendor oversight
Scaling the organization
Tight deadlines for regulatory submissions
Identifying bottlenecks in automated processes
Process inefficiencies in fp&a
Scaling fp&a tools
Data integrity and consistency
Metadata alignment
Optimizing data pipelines for ai model training
Enhancing data storage for analytics

▲Active Projects

Recruiting strategy across software, ai/ml, chemistry, biology and clinical roles
Quality roadmap development
Compound library campaigns
Scale bench-scale chemistry to high-throughput processes
Scalable fp&a tools development
Long-range planning initiatives
Financial planning process leadership
Drug discovery platform
Dmta process platform
Improve recruiting process, pipeline reporting, analytics

Hiring Activity

Accelerating20 roles · 15 in 30d

Department

Research

8

HR

4

Finance

2

Data

1

Engineering

1

Healthcare

1

Legal

1

Ops

1

Seniority

Senior

12

Mid

3

Director

2

Lead

2

Manager

1

Principal

1

Company intelligence

Find more companies like Iambic Therapeutics by tech stack, pain points and active projects

Get started free

About Iambic Therapeutics

Iambic Therapeutics develops novel medicines using an AI-driven platform that combines computational drug discovery with wet-lab chemistry. Founded in 2020 and based in San Diego, the company has moved multiple candidates into human clinical trials, a marker of validated IP and regulatory progress. The team spans AI researchers, computational chemists, and clinical experts. Current operational focus includes scaling bench-scale chemistry workflows to high-throughput automation, building out financial planning and analytics infrastructure, and expanding recruiting across software, AI/ML, chemistry, and clinical disciplines. The company is hiring in the United States and Germany.

HeadquartersSan Diego, California

Company Size51–200 employees

Founded2020

Hiring MarketsUnited States, Germany

Frequently Asked Questions

What is Iambic Therapeutics working on?

Iambic builds an AI-driven drug discovery platform focused on advancing novel molecules into human clinical trials. Active projects include scaling bench-scale chemistry to high-throughput processes, developing a DMTA (decision-making table assumption) platform for drug discovery workflows, and optimizing data pipelines for AI model training.

What tech stack does Iambic Therapeutics use?

The stack combines laboratory automation (HPLC, qPCR, Agilent), data/ML (Python, FastAPI, Databricks, Apache Spark, Airflow, Argo CD, Prefect), regulatory (Veeva), and business operations (NetSuite, Anaplan, Adaptive Planning). KNIME and Pydantic appear in analytical workflows.